Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis

J Chen, X Zhang, R Millican, J Sherwood… - Advanced drug delivery …, 2021 - Elsevier
Atherosclerosis is a chronic inflammatory disease driven by lipid accumulation in arteries,
leading to narrowing and thrombosis. It affects the heart, brain, and peripheral vessels and is …

Recent advances in managing atherosclerosis via nanomedicine

CKW Chan, L Zhang, CK Cheng, H Yang, Y Huang… - Small, 2018 - Wiley Online Library
Atherosclerosis, driven by chronic inflammation of the arteries and lipid accumulation on the
blood vessel wall, underpins many cardiovascular diseases with high mortality rates …

Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis

Y Dou, Y Chen, X Zhang, X Xu, Y Chen, J Guo… - Biomaterials, 2017 - Elsevier
Atherosclerosis is the leading cause of many fatal cardiovascular and cerebrovascular
diseases. Whereas nanomedicines are promising for targeted therapy of atherosclerosis …

Glycosphingolipids in diabetes, oxidative stress, and cardiovascular disease: prevention in experimental animal models

A Balram, S Thapa, S Chatterjee - International journal of molecular …, 2022 - mdpi.com
Diabetes contributes to about 30% morbidity and mortality world-wide and has tidal wave
increases in several countries in Asia. Diabetes is a multi-factorial disease compounded by …

Nanoparticles: promising tools for the treatment and prevention of myocardial infarction

Q Pan, J Xu, CJ Wen, YY Xiong, ZT Gong… - International Journal of …, 2021 - Taylor & Francis
Despite several recent advances, current therapy and prevention strategies for myocardial
infarction are far from satisfactory, owing to limitations in their applicability and treatment …

Advances in glycosylation-mediated cancer-targeted drug delivery

L Cai, Z Gu, J Zhong, D Wen, G Chen, L He, J Wu… - Drug discovery today, 2018 - Elsevier
Highlights•Aberrant tumor glycosylation has been used as a molecular target for cancer
therapy.•Advances in glycosylated strategies are allowing better targeted drug …

Lysosome (Dys) function in atherosclerosis—a big weight on the shoulders of a small organelle

ARA Marques, C Ramos… - Frontiers in cell and …, 2021 - frontiersin.org
Atherosclerosis is a progressive insidious chronic disease that underlies most of the
cardiovascular pathologies, including myocardial infarction and ischemic stroke. The …

N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive H2S donor via targeting E-selectin receptor and CD44 receptor for the …

Q Chen, C Guo, X Zhou, Y Su, H Guo, M Cao… - International Journal of …, 2022 - Elsevier
Currently, very limited therapeutic approaches are available for the drug treatment of
atherosclerosis (AS). H 2 S-donor is becoming a common trend in much life-threatening …

Potential therapeutic targets for atherosclerosis in sphingolipid metabolism

Z Yu, Q Peng, Y Huang - Clinical Science, 2019 - portlandpress.com
Sphingolipids, such as sphingomyelins, ceramides, glycosphingolipids, and sphingosine-1-
phosphates (S1P) are a large group of structurally and functionally diverse molecules. Some …

Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: an update for 2015–2016

DJ Harvey - Mass Spectrometry Reviews, 2021 - Wiley Online Library
This review is the ninth update of the original article published in 1999 on the application of
matrix‐assisted laser desorption/ionization (MALDI) mass spectrometry to the analysis of …